only compared the cardiovascular effects of SGLT2-Is and GLP1-RAs in Asian versus White populations with and without T2D.54 The results suggested differential treatment effects of SGLT2-Is and GLP-1RAs by race (White and Asian populations), with greater benefits of both classes of drugs in Asians. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.